Cardiovascular Event Prediction by Machine Learning: The Multi-Ethnic Study of Atherosclerosis
- PMID: 28794054
- PMCID: PMC5640485
- DOI: 10.1161/CIRCRESAHA.117.311312
Cardiovascular Event Prediction by Machine Learning: The Multi-Ethnic Study of Atherosclerosis
Abstract
Rationale: Machine learning may be useful to characterize cardiovascular risk, predict outcomes, and identify biomarkers in population studies.
Objective: To test the ability of random survival forests, a machine learning technique, to predict 6 cardiovascular outcomes in comparison to standard cardiovascular risk scores.
Methods and results: We included participants from the MESA (Multi-Ethnic Study of Atherosclerosis). Baseline measurements were used to predict cardiovascular outcomes over 12 years of follow-up. MESA was designed to study progression of subclinical disease to cardiovascular events where participants were initially free of cardiovascular disease. All 6814 participants from MESA, aged 45 to 84 years, from 4 ethnicities, and 6 centers across the United States were included. Seven-hundred thirty-five variables from imaging and noninvasive tests, questionnaires, and biomarker panels were obtained. We used the random survival forests technique to identify the top-20 predictors of each outcome. Imaging, electrocardiography, and serum biomarkers featured heavily on the top-20 lists as opposed to traditional cardiovascular risk factors. Age was the most important predictor for all-cause mortality. Fasting glucose levels and carotid ultrasonography measures were important predictors of stroke. Coronary Artery Calcium score was the most important predictor of coronary heart disease and all atherosclerotic cardiovascular disease combined outcomes. Left ventricular structure and function and cardiac troponin-T were among the top predictors for incident heart failure. Creatinine, age, and ankle-brachial index were among the top predictors of atrial fibrillation. TNF-α (tissue necrosis factor-α) and IL (interleukin)-2 soluble receptors and NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide) levels were important across all outcomes. The random survival forests technique performed better than established risk scores with increased prediction accuracy (decreased Brier score by 10%-25%).
Conclusions: Machine learning in conjunction with deep phenotyping improves prediction accuracy in cardiovascular event prediction in an initially asymptomatic population. These methods may lead to greater insights on subclinical disease markers without apriori assumptions of causality.
Clinical trial registration: URL: http://www.clinicaltrials.gov. Unique identifier: NCT00005487.
Keywords: atrial fibrillation; cardiovascular disease; coronary heart disease; heart failure; machine learning; mortality; stroke.
© 2017 American Heart Association, Inc.
Figures
Comment in
-
Cardiovascular Risk Prediction: Widening the Net.Circ Res. 2017 Oct 13;121(9):1032-1033. doi: 10.1161/CIRCRESAHA.117.311868. Circ Res. 2017. PMID: 29025755 No abstract available.
References
-
- Lloyd-Jones DM. Cardiovascular Risk Prediction: Basic Concepts, Current Status, and Future Directions. Circulation. 2010;121:1768–1777. - PubMed
-
- Wong ND. Epidemiological studies of CHD and the evolution of preventive cardiology. Nat Rev Cardiol. 2014;11:276–289. - PubMed
-
- Gorodeski EZ, Ishwaran H, Kogalur UB, Blackstone EH, Hsich E, Zhang Z-m, Vitolins MZ, Manson JE, Curb JD, Martin LW. Use of Hundreds of Electrocardiographic Biomarkers for Prediction of Mortality in Postmenopausal Women The Women’s Health Initiative. Circulation: Cardiovascular Quality and Outcomes. 2011 CIRCOUTCOMES.110.959023. - PMC - PubMed
-
- Bild DE, Bluemke DA, Burke GL, Detrano R, Diez Roux AV, Folsom AR, Greenland P, Jacob DR, Jr, Kronmal R, Liu K, Nelson JC, O’Leary D, Saad MF, Shea S, Szklo M, Tracy RP. Multi-ethnic study of atherosclerosis: objectives and design. Am J Epidemiol. 2002;156:871–81. - PubMed
-
- Akaike H. Likelihood of a model and information criteria. Journal of econometrics. 1981;16:3–14.
Publication types
MeSH terms
Associated data
Grants and funding
- R01 HL066075/HL/NHLBI NIH HHS/United States
- N01 HC095161/HL/NHLBI NIH HHS/United States
- N01 HC095168/HL/NHLBI NIH HHS/United States
- N01 HC095167/HL/NHLBI NIH HHS/United States
- N01 HC095159/HL/NHLBI NIH HHS/United States
- N01 HC095163/HL/NHLBI NIH HHS/United States
- UL1 TR000040/TR/NCATS NIH HHS/United States
- N01 HC095166/HL/NHLBI NIH HHS/United States
- N01 HC095162/HL/NHLBI NIH HHS/United States
- N01 HC095160/HL/NHLBI NIH HHS/United States
- UL1 TR001079/TR/NCATS NIH HHS/United States
- N01 HC095169/HL/NHLBI NIH HHS/United States
- N01 HC095165/HL/NHLBI NIH HHS/United States
- N01 HC095164/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
